Global Information
회사소개 | 문의 | 비교리스트

세계의 OTC/DTC 감염증 진단 시장 : 전략, 동향, 예측(2020-2024년) - 코로나바이러스감염증-19에 의한 수정 예측 포함

OTC/DTC Infectious Disease Diagnostics Strategies and Trends. Covid-19 Adjusted Forecasts by Application by Channel by Country. With Market Analysis, Executive Guides, Customization and Covid-19 Market Opportunity Analysis. 2020 to 2024

리서치사 Howe Sound Research
발행일 2020년 05월 상품 코드 933294
페이지 정보 영문 394 Pages
가격
US $ 6,995 ₩ 8,743,000 PDF by E-mail (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1대의 PC에서만 이용할 수 있는 라이선스로 인쇄가 불가능합니다.
US $ 10,495 ₩ 13,118,000 PDF by E-mail (Five User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 5대의 PC에서만 이용할 수 있는 라이선스로 인쇄가 불가능합니다.
US $ 13,995 ₩ 17,493,000 PDF by E-mail (Enterprise License) help
동일기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 편집 및 인쇄는 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 OTC/DTC 감염증 진단 시장 : 전략, 동향, 예측(2020-2024년) - 코로나바이러스감염증-19에 의한 수정 예측 포함 OTC/DTC Infectious Disease Diagnostics Strategies and Trends. Covid-19 Adjusted Forecasts by Application by Channel by Country. With Market Analysis, Executive Guides, Customization and Covid-19 Market Opportunity Analysis. 2020 to 2024
발행일 : 2020년 05월 페이지 정보 : 영문 394 Pages

DTC에서는 유전자 검사가 선도하고 있습니다. 현재 감염증 검사가 소비자용 직접 검사로 이동하고 있습니다. 새로운 샘플링 기술, 신속하고 멀티플렉스인 검사에 의해 검사 방법과 검사 장소의 상황이 변화했습니다. 코로나바이러스감염증-19(COVID-19) 상황이 그 주도권을 쥐고 있습니다.

세계의 OTC/DTC 감염증 진단(OTC/DTC Infectious Disease Diagnostics) 시장에 대해 조사 분석했으며, 시장 개요, 전략, 동향, 예측에 대한 체계적인 정보를 제공합니다.

목차

제1장 서론과 시장 정의

  • OTC 검사와 DTC 검사
  • OTC/DTC 검사 - 진단의 조용한 혁명
  • 자기 vs. 발송
  • OTC, DTC, HxV, HSG
  • 조사 방법
  • 미국의 의료 시장과 임상 검사 - 전망

제2장 감염증 - 병원체 설명

  • HIV - 인체면역결핍바이러스(AIDS)
  • HBV - B형 간염
  • HCV - C형 간염
  • HPV - 인유두종바이러스
  • 코로나바이러스
  • 인플루엔자
  • CT/NG - 클라미디아/임질
  • UTI
  • GAS
  • RESP

제3장 업계 개요

  • 진출 기업
  • 임상 검사실 시장 부문
  • 업계 구조

제4장 시장 동향

  • 성장 촉진요인
  • 성장 억제요인
  • 진단 기술의 발전

제5장 OTC/DTC 감염증 검사의 최근 동향

  • 최근의 동향 - 중요성
  • FemtoDx가 COVID-19에 대한 재택 신속 검사 개발을 개시
  • FDA가 최초의 재택 코로나바이러스 검사를 승인
  • 무료 재택 HIV 검사로 보다 많은 감염을 검출
  • 바이오 해킹 동향은 자기 검사를 서포트
  • PerkinElmer와 EverlyWell이 미국의 재택 건강진단 시장을 확대 등

제6장 진단 검사의 주요 기업 개요

  • 1DropDiagnostics
  • Abbott Diagnostics(Alere)
  • Atomo Diagnostics
  • Ador Diagnostics
  • Akkoni Biosystems
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Biocartis
  • BioFire Diagnostics
  • bioMerieux
  • Bio-Rad Laboratories
  • Bosch Healthcare Solutions GmbH
  • Cepheid
  • Curetis
  • DBS Systems
  • Diagenode Diagnostics
  • Diasorin
  • Everlywell
  • Fusion Genomics.
  • GenePOC Diagnostics
  • GenMark Dx
  • Healthy.IO
  • Hologic
  • Inflammatix
  • Inui Health
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Labcorp - Pixel
  • Letsgetchecked
  • Lexigene
  • Luminex
  • Mbio Diagnostics
  • Mesa Biotech
  • Mobidiag
  • myLabBox
  • Mylan
  • Nanomix
  • Orasure
  • Oxford Nanopore
  • Panagene
  • Primerdesign
  • Prominex
  • Qiagen(Statdx)
  • Quantumdx
  • Quest Diagnostics - Quest Direct
  • Roche Molecular Diagnostics
  • Scanwell Health
  • Seegene
  • Sensovation
  • Seventh Sense Biosystems
  • Siemens Healthineers(Fast Track Diagnostics)
  • SkylineDx
  • T2 Biosystems
  • TestCard Diagnostics
  • Thermo Fisher
  • Thriva
  • Veramarx
  • XCR Diagnostics

제7장 세계 시장 규모

  • 세계 시장 규모 : 국가별
  • 세계 시장 규모 : 증후군별

제8장 세계 시장 : 증후군별

  • 호흡기 증후군 시장(COVID-19 포함)
  • STD 시장
  • UTI 시장
  • HxV 시장
  • 기타 시장

제9장 세계 시장 : 채널별

  • OTC/DTC 시장 : 채널별
  • OTC 시장
  • DTC 시장
  • HSG 시장
KSM 20.05.07

Table of Tables

  • Table 1 Medicare Clinical Lab Expenditures Actual & Forecast 2014 to 2024 ($Billion)
  • Table 2 Classification of HIV Species
  • Table 3 HBV Tests - CMS Codes & Prices
  • Table 4 HCV Tests - CMS Codes & Prices
  • Table 5 HPV Clearance Rates
  • Table 6 HPV Tests - CMS Codes & Prices
  • Table 7 HPV Tests, Technology, Types
  • Table 8 Characteristics of Coronavirus Pandemic Infections
  • TABLE 9 COVID-19 SYMPTOMS
  • Table 10 DTC COVID-19 TESTS and CURRENT STAS
  • Table 11 Types of Influenza Tests
  • Table 12 Influenza Tests - CMS Codes & Prices
  • Table 13 FDA Cleared Molecular Assays for Influenza
  • Table 14 FDA Cleared NAAT CTGC Tests
  • Table 15 CTGC NAAT Target Sequences and Possible False Reactions
  • Table 16 CT/NG Tests - CMS Codes & Prices
  • Table 17 GAS Panel BioFire
  • Table 18 BioFire RESP Panel
  • Table 19 Market Players by Type
  • Table 20 Clinical Laboratory Departments and Segments
  • Table 21 Laboratory Management Focus - Different Approaches
  • Table 22 Key Segmentation Variables Going Forward
  • Table 23 Possible Market Segments of OTC/DTC Market
  • Table 24 Five Factors Driving Growth
  • Table 25 Four Factors Limiting Growth
  • Table 26 Self vs. Send TAT
  • Table 27 OTC/DTC ID Global Market by Country/Region
  • Table 28 OTC/DTC ID Global Market by Syndrome
  • Table 29 STD Testing market by country
  • Table 30 UTI Testing market by country
  • Table 31 HxV Testing market by country
  • Table 32 Other Testing market by country
  • Table 33 DTC Testing market by country
  • Table 34 HSG Testing market by country
  • Table 35 2020 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 Medicare Clinical Lab Expenditures 2014 to 2024 ($Million)
  • Figure 2 HIV Virion
  • Figure 3 Diagram of the HIV Replication Cycle
  • Figure 4 The Structure of the HBV Virus
  • Figure 5 Hepatitis B Replication
  • Figure 6 Structure of the HCV Virus
  • Figure 7 HCV Replication Cycle
  • FIGURE 8 STRUCTURE OF CORONAVIRUSES
  • Figure 9 Structure of the Influenza Virion
  • Figure 10 Influenza Replication
  • Figure 11 Chart Death Rates and Infectious Disease Decline
  • Figure 11 The Multiplex Paradigm Shift
  • Figure 13 Market Size by Country - Key Countries
  • Figure 14 Chart of Global Market by Syndrome by Year
  • Figure 15 Syndrome Segment Shares 2019 vs 2014
  • Figure 16 Syndrome Share 2019
  • Figure 17 Syndrome Share 2024
  • Figure 18 Chart - Respiratory market 5 Year Growth
  • Figure 19 Chart - STD market 5 Year Growht
  • Figure 20 Chart - UTI 5 Year market Growth
  • Figure 21 Chart - HxV market 5 Year Growth
  • Figure 22 Chart - Other market 5 Year Growth
  • Figure 23 Channel Share by Year
  • Figure 24 Chart - OTC Channel 5 Year Growth
  • Figure 25 Chart - DTC Channel 5 Year Growth
  • Figure 26 Chart - HSG Channel 5 Year Growth

OVERVIEW:

Over the Counter and Direct to Consumer diagnostics set to help solve the pandemic problem. New technologies create rapid test solutions for the home market. Self-Sampling technology key.

Genetic DTC testing led the way. Now Infectious disease testing is moving directly to the consumer. New sampling technology, rapid and multiplex tests have changed the picture on how and where testing is done. And the COVID-19 situation will lead the charge. This report explores the DTC outlook for different syndromes. Find out where the action is and the learn about the players.

Exciting technical developments especially in the seesaw between PCR and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even CRISPR diagnostics are now coming into play.

The report has hundreds of pages of information including a complete list of Current 2019 United States Medicare Fee Payment Schedules to help sharpen your pricing.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

  • iA. Situation Analysis and COVID-19 Market Analysis
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1 What is OTC and DTC Testing?
  • 1.2 OTC/DTC Testing - the quiet revolution in diagnostics
  • 1.3 Self vs. Send - who knew?
  • 1.4 Market Definition
    • 1.4.1 Retail vs. Wholesale
  • 1.42 OTC, DTC, HxV and HSG
    • 1.4.3 Currency
    • 1.4.4 Years
  • 1.5 Methodology
    • 1.5.1 Authors
    • 1.5.2 Sources
  • 1.6 U.S. Medical Market and Clinical Laboratory Testing - Perspective
    • 1.6.1 U.S. Medicare Expenditures for Clinical Testing

2. The Infectious Diseases - Guide to the Pathogens

  • 2.1 HIV - Human Immunodeficiency Virus (AIDS)
    • 2.1.1 Virology
      • 2.1.1.1 Classification
      • 2.1.1.2 Structure and genome
      • 2.1.1.3 Tropism
      • 2.1.1.4 Replication cycle
      • 2.1.1.5 Genetic variability
    • 2.1.2 Diagnosis
    • 2.1.3 Testing
      • 2.1.3.1 Antibody tests
      • 2.1.3.2 Point of Care Tests (POCT)
      • 2.1.3.4 Antigen Tests
      • 2.1.3.5 Nucleic acid-based tests (NAT)
      • 2.1.3.6 Other tests used in HIV treatment
  • 2.2 HBV - Hepatitis B
    • 2.2.1 Virology
      • 2.2.1.1 Genome
      • 2.2.1.2 Pathogenesis
      • 2.2.1.3 Hepatitis B virus replication
      • 2.2.1.4 Serotypes and genotypes
    • 2.2.2 Mechanisms
    • 2.2.3 Diagnosis
    • 2.2.4 Market Opportunity Analysis
  • 2.3 HCV - Hepatitis C
    • 2.3.1 Taxonomy
      • 2.3.2.1 Structure
      • 2.3.2.2 Genome
    • 2.3.3 Molecular biology
    • 2.3.4 Replication
    • 2.3.5 Genotypes
      • 2.3.5.1 Clinical importance
    • 2.3.6 Market Opportunity Analysis
  • 2.4 HPV - Human papillomavirus
    • 2.4.1 Virology
      • 2.4.1.1 E6/E7 proteins
      • 2.4.1.2 Role in cancer
      • 2.4.1.3 E2 research
      • 2.4.1.4 Latency period
      • 2.4.1.5 Clearance
    • 2.4.2 Diagnosis
      • 2.4.2.1 Cervical testing
      • 2.4.2.2 Oral testing
      • 2.4.2.3 Testing men
      • 2.4.2.4 Other testing
    • 2.4.3 Market Opportunity Analysis
  • 2.5 Coronavirus
    • 2.5.1 Severe acute respiratory syndrome (SARS)
    • 2.5.2 Middle East respiratory syndrome (MERS)
    • 2.5.3 COVID-19. The SARS CoV 2 Virus
      • 2.5.3.1 Signs and symptoms
      • 2.5.3.2 Transmission
      • 2.5.3.3 Diagnosis
      • 2.5.3.4 Prevention
      • 2.5.3.5 Management
      • 2.5.3.6 Prognosis
    • 2.5.4 Pandemic Diagnostics
      • 2.5.4.1 Risk Management - Spark and Spread
      • 2.5.4.2 Dx Technology - Nucleic Acid Based
      • 2.5.4.3 Dx Technology - Immunoassay
      • 2.5.4.4 Time to Market and Preparedness Issues
    • 2.5.5 COVID-19 Market Opportunity Analysis - A Special Case
    • 2.5.6 Current COVID-19 DTC Tests
  • 2.6 Influenza
    • 2.6.1 Flu
      • 2.6.1.1 Types of virus
      • 2.6.1.2 Influenzavirus A
      • 2.6.1.3 Influenzavirus B
      • 2.6.1.4 Influenzavirus C
      • 2.6.1.5 Structure, properties, and subtype nomenclature
      • 2.6.1.6 Replication
    • 2.6.2 Testing
      • 2.6.2.1 Advantages/Disadvantages of Molecular Assays
    • 2.6.3 Market Opportunity Analysis
  • 2.7 CT/NG - Chlamydia/Gonorhea
    • 2.7.1 Gonorrhea
      • 2.7.1.1 Diagnosis
      • 2.7.1.2 Screening
    • 2.7.2 Chlamydia
      • 2.7.2.1 Diagnosis
      • 2.7.2.2 Screening
    • 2.7.3 Testing
      • 2.7.3.1 Nucleic acid amplification tests (NAATs).
      • 2.7.3.2 Performance of NAAT Tests
    • 2.7.4 Market Opportunity Analysis
  • 2.8 UTI
    • 2.8.1 Diagnosis
    • 2.8.2 Testing
      • 2.8.2.1 Nitrites test
      • 2.8.2.2 Leukocytes test
    • 2.8.3 Market Opportunity Analysis
  • 2.9 GAS
    • 2.9.1 Infectious Agents
    • 2.9.2 Market Opportunity Analysis
  • 2.10 RESP
    • 2.10.1 Diagnosis
    • 2.10.2 Market Opportunity Analysis

3. Industry Overview

  • 3.1 Industry Participants
    • 3.1.1 IVD Supplier
    • 3.1.2 Independent lab specialized/esoteric
    • 3.1.3 Independent lab national/regional
    • 3.1.4 Independent lab analytical
    • 3.1.5 Public National/regional lab
    • 3.1.6 Hospital lab
    • 3.1.7 Physician lab
    • 3.1.8 Pharmacies
    • 3.1.9 Audit body
  • 3.2 The Clinical Laboratory Market Segments
    • 3.2.1 Traditional Market Segmentation
    • 3.2.2 Laboratory Focus and Segmentation
    • 3.2.3 Segmenting the OTC/DTC Market
  • 3.3 Industry Structure
    • 3.3.1 Hospital Testing Share
    • 3.3.2 Economies of Scale
      • 3.3.2.1 Hospital vs. Central Lab
    • 3.3.3 Physician Office Lab's
      • 3.3.3.1 The Problem with POLS
    • 3.3.4 Physician's and OCT/DTC
    • 3.3.5 Pharmacies and OCT/DTC
      • 3.3.5.1 The Diagnostic Plight of Pharmacies - Trying to do good
      • 3.3.5.2 The Theranos Legacy

4. Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Privacy and Anonymity
    • 4.1.2 The Internet Effect.
    • 4.1.3 Rapid Result.
    • 4.1.4 The Wellness Movement
    • 4.1.5 The COVID-19 Impact.
  • 4.2 Factors Limiting Growth
    • 4.2.1 Trust Factor
    • 4.2.2 Infectious Disease is Declining But....
    • 4.2.3 Wellness Hurts
    • 4.2.4 Economic Growth improves Living Standards
  • 4.3 Diagnostic Technology Development
    • 4.3.1 The Multiplex Paradigm Shift
    • 4.3.2 NAT vs. Lateral Flow
    • 4.3.3 The Unusual Role of GPS
    • 4.3.4 Self and Send Competition
    • 4.4.5 The Relationship to DTC Genetic
    • 4.4.6 The Relationship to TeleHealth
    • 4.4.7 Sample Collection - Who Knew?

5. OTC/DTC Infectious Disease Testing Recent Developments

  • Recent Developments - Importance and How to Use This Section
  • Importance of These Developments
  • How to Use This Section
  • FemtoDx Launches Rapid At-Home Test Development for COVID-19
  • FDA approves first at-home coronavirus test
  • Free Home HIV Tests Detect More Infections
  • Biohacking trend supports self testing.
  • PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market
  • Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self-Test
  • Miraca Holdings Inc. and Seventh Sense Biosystems, Inc. Announce Distribution Agreement
  • OraSure Technologies, Inc. Announces Two Acquisitions
  • Mylan signs HIV test commercialisation deal with Atomo Diagnostics
  • Nigerian Govt Approves Alere HIV Self-Test Kit
  • Rapid HIV tests vary in their accuracy
  • Montreal researchers develop HIV self-testing app
  • Boots launches UTI test and treat service across 37 branches
  • Scanwell Health moves beyond home UTI testing with nationwide kidney disease study partnership
  • Healthy.io raises $18 million for at-home urinalysis tests
  • LetsGetChecked collects $30M more for at-home health testing
  • TestCard, a $4 Urine Test Read by Smartphone
  • Digital Health Startup EverlyWell Raises $50M
  • Thriva adds test-at-home kits for female hormone and cortisol stress
  • Tasso scores $6.1M for patch-based home blood testing
  • LabCorp to offer self-testing home kits
  • 1Drop Diagnostics draws $4.25M for portable blood diagnostic panel
  • DBS Systems HEMAXIS receives CE/IVD mark
  • myLAB Box Announces $1.56M in Seed Funding
  • Abbott HbA1c point-of-care test reliably diagnoses diabetes

6. Profiles of Key Diagnostic Testing Companies

  • 1DropDiagnostics
  • Abbott Diagnostics (Alere)
  • Atomo Diagnostics
  • Ador Diagnostics
  • Akkoni Biosystems
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Biocartis
  • BioFire Diagnostics
  • bioMérieux
  • Bio-Rad Laboratories
  • Bosch Healthcare Solutions GmbH
  • Cepheid
  • Curetis
  • DBS Systems
  • Diagenode Diagnostics
  • Diasorin
  • Everlywell
  • Fusion Genomics.
  • GenePOC Diagnostics
  • GenMark Dx
  • Healthy.IO
  • Hologic
  • Inflammatix
  • Inui Health
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Labcorp - Pixel
  • Letsgetchecked
  • Lexigene
  • Luminex
  • Mbio Diagnostics
  • Mesa Biotech
  • Mobidiag
  • myLabBox
  • Mylan
  • Nanomix
  • Orasure
  • Oxford Nanopore
  • Panagene
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Quest Diagnostics - Quest Direct
  • Roche Molecular Diagnostics
  • Scanwell Health
  • Seegene
  • Sensovation
  • Seventh Sense Biosystems
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • T2 Biosystems
  • TestCard Diagnostics
  • Thermo Fisher
  • Thriva
  • Veramarx
  • XCR Diagnostics

7. Global Market Size

  • 7.1 OTC/DTC ID Global Market Size by Country with Charts
  • 7.2 OTC/DTC ID Global Market Size by Syndrome with Charts

8. Global Market by Syndrome

  • 8.1 Respiratory Syndrome Market (including COVID-19)
    • 8.1.1 Respiratory Syndrome Market by Country
  • 8.2 STD Market
    • 8.2.1 STD Market by Country with Chart
  • 8.3 UTI Market
    • 8.3.1 UTI Market by Country with Chart
  • 8.4 HxV Market
    • 8.4.1 HxV Market by Country with Chart
  • 8.5 Other Market
    • 8.5.1 Other Market by Country with Chart

9. Global Market by Channel

  • 9.1 OTC/DTC Market by Channel
    • 9.1.1 OTC/DTC Market by Channel with Chart
  • 9.2 OTC Market
    • 9.2.1 OTC Market by Country
  • 9.3 DTC Market
    • 9.3.1 DTC Market by Country with Chart
  • 9.4 HSG Market
    • 9.4.1 HSG Market by Country with Chart

Appendices

  • I. United States Medicare System: 2020 Clinical Laboratory Fees Schedule
  • II. FDA Approved Microbial Tests
Back to Top
전화 문의
F A Q